Crestwood Advisors Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Crestwood Advisors Group's RGEN Position: Q1 2026 in Review
Crestwood Advisors Group sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,715 shares — an estimated $281K sold.
Crestwood Advisors Group first reported a position in RGEN in Q1 2025 and held it in 4 quarters. The position peaked at $464K in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Crestwood Advisors Group reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Crestwood Advisors Group sold 1,715 Repligen shares in Q1 2026, an estimated $281K.
- Crestwood Advisors Group first reported a position in Repligen in Q1 2025 and held it in 4 quarters.
- Crestwood Advisors Group's Repligen position peaked at $464K in Q1 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.